ARROWHEAD PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2016 to 2023.
  • Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was $64.8M.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$96.2M, a 1675% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$5.42M, a 96.2% increase from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$142M, a 41.2% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$96.2M -$90.7M -1675% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-29
2022 -$5.42M +$136M +96.2% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-29
2021 -$142M +$99.1M +41.2% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 -$241M -$193M -404% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2019 -$47.7M -$40.3M -542% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-22
2018 -$7.43M +$41.2M +84.7% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-23
2017 -$48.6M -$62.1M -462% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-25
2016 $13.4M Oct 1, 2015 Sep 30, 2016 10-K 2018-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.